Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 18, 2025Conduction system pacing technique may promote greater ventricular synchrony and reduce long-term risk of heart failure associated with traditional right ventricular pacing
PARIS, France, 18 September 2025 – Boston Scientific Corporation (NYSE: BSX) has received CE mark approval to expand the indication for its current-generation INGEVITY™+ Pacing Leads – thin...
-
Jul 24, 2025CE MDR approval for basivertebral nerve ablation therapy designed to provide long-lasting relief from single procedure
HEMEL HEMPSTEAD, United Kingdom, 24 July, 2025 — Boston Scientific Corporation (NYSE: BSX) today announced CE mark and first procedure in Europe with the Intracept Intraosseous Nerve Ablation...
-
Jul 10, 2025Positive guidance for the Boston Scientific FARAPULSE™ Pulsed Field Ablation System marks expansion of minimally invasive treatment options for growing number of atrial fibrillation patients in the UK.
HEMEL HEMPSTEAD, United Kingdom, 10 July 2025 – Boston Scientific Corporation (NYSE: BSX) today welcomed guidance1 supporting the use of pulsed field ablation (PFA) for the treatment of atrial...
-
Jul 10, 2025Una evaluación positiva para el sistema de ablación por campo pulsado FARAPULSE™ amplía las opciones de tratamiento mínimamente invasivas para un número creciente de pacientes con fibrilación auricular
HEMEL HEMPSTEAD, Reino Unido, 10 de julio de 2025 – Boston Scientific Corporation (NYSE: BSX) celebra hoy la publicación de la guía¹ del Instituto Nacional para la Excelencia en Salud y...
-
Mar 3, 2025
Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass., March 3, 2025 /PRNewswire/ --...